[HTML][HTML] Hepatitis C virus/human T lymphotropic virus 1/2 co-infection: Regional burden and virological outcomes in people who inject drugs
E Castro, E Roger - World journal of virology, 2016 - ncbi.nlm.nih.gov
This review analyses current data concerning co-infection with hepatitis C virus (HCV) and
human T lymphotropic virus (HTLV)-1/2 in people who inject drugs (PWID), with a particular …
human T lymphotropic virus (HTLV)-1/2 in people who inject drugs (PWID), with a particular …
Current views on interferon therapy for HIV
A Rivero-Juárez, M Frias, A Rivero - Expert opinion on biological …, 2016 - Taylor & Francis
Introduction: Knowledge of IFN-antiviral activity against HIV infection dates from the first
years of the AIDS epidemic. Recombinant IFN had an inhibitory effect on HIV and was not …
years of the AIDS epidemic. Recombinant IFN had an inhibitory effect on HIV and was not …
Time course of cellular HIV-DNA and low-level HIV viremia in HIV–HCV co-infected patients whose HCV infection had been successfully treated with directly acting …
SG Parisi, S Andreis, M Basso, S Cavinato… - Medical microbiology …, 2017 - Springer
This longitudinal study described cellular HIV-DNA changes and their correlation with HIV
low-level plasma viremia (LLV) in HIV–HCV co-infected patients on successful antiretroviral …
low-level plasma viremia (LLV) in HIV–HCV co-infected patients on successful antiretroviral …
Peginterferon α-2a for the treatment of HIV infection
DM Asmuth, NS Utay, RB Pollard - Expert Opinion on …, 2016 - Taylor & Francis
Introduction: Novel approaches are urgently needed to achieve the next level of control of
HIV infection beyond antiretroviral medications that will lead to the ultimate goal of curing …
HIV infection beyond antiretroviral medications that will lead to the ultimate goal of curing …